3-allyl-6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine-7,8-diol hydrobromide

Catalog No. :
ACQZNM066
CAS No. :
74115-01-8
Molecular Formula :
C19H21BrClNO2
Molecular Weight :
410.74

IUPAC Name:3-allyl-6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine-7,8-diol hydrobromide

3-allyl-6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine-7,8-diol hydrobromide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-allyl-6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine-7,8-diol hydrobromide
IUPAC Name3-allyl-6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine-7,8-diol hydrobromide
Molecular FormulaC19H21BrClNO2
Molecular Weight410.74
SMILESBr.C=CCN1CCC2=C(Cl)C(O)=C(O)C=C2C(C2=CC=CC=C2)C1
InChI KeyWLXGFAVTAAQOFH-UHFFFAOYSA-N
Synonym(+/-)-chloro-APB;1H-3-Benzazepine-7,8-diol,6-chloro-2,3,4,5-tetrahydro-1-phenyl-3-(2-propen-1-yl)-, hydrobromide (1:1);6-Chloro-2,3,4,5-tetrahydro-1-phenyl-3-(2-propen-1-yl)-1H-3-benzazepine-7,8-diol hydrobromide;(±)-SKF 82958 HYDROBROMIDE;CHLORO-APB HYDROBROMIDE;SKF 82958 hydrobromide,SKF82958 hydrobromide;(+/-)-6-Chloro-7,8-dihydroxy-3-allyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine HBr;SKF-82958 hydrobromide ((±)-SKF 82958 hydrobromide
CAS No.74115-01-8

Synthetic Route by SureRoute

1. ACQZNM066 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQZNM066 route product structure diagram
    ACQZNM06674115-01-8
Inquiry

2. ACQZNM066 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQZNM066 route product structure diagram
    ACQZNM06674115-01-8
Inquiry

Comments (0)